Every cancer doc I talk to says Margetuximab may get approved, but no onc doc will prescribe it. I don't get today's action. I mean I'll take it--I have a tiny position--but nothing I read in the PR justifies this kind of movement in the share price.
Market Data 
Markets 
AI
